You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Automated Method for Measurement of Hearing Sensitivity

    SBC: AUDIOLOGY, INC            Topic: N/A

    N/A

    STTR Phase I 2003 Department of Health and Human ServicesNational Institutes of Health
  2. Automated Test of Word Recognition- Phase I

    SBC: AUDIOLOGY, INC            Topic: N/A

    DESCRIPTION (provided by applicant): Over 5 million word recognition tests are administered annually by audiologists in the United States with an associated cost of more then $100 million. These tests are currently performed manually by high-trained audiologists. This application describes a Phase I development of an automated clinical speech recognition test using clinical test recordings and an ...

    STTR Phase I 2003 Department of Health and Human ServicesNational Institutes of Health
  3. PPMP as a Ceramide Catabolism Inhibitor for Chemotherapy

    SBC: AVANTI POLAR LIPIDS, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Our goal is to develop 1-phenyl-2-palmitoylamino-3-morpholino-1-propanol (PPMP) as a clinical inhibitor of ceremide catabolism, in order to enhance the anti-cancer activity of the cytotoxic retinoid, fenretinide (4-HPR). We have reported that 4-HPR increased ceramide in numerous pediatric and adult solid cancer and leukemia cell lines in vitro. We have also ...

    STTR Phase I 2003 Department of Health and Human ServicesNational Institutes of Health
  4. Ultra-micro oxygen sensor development

    SBC: Biocurrents Research, Inc.            Topic: N/A

    DESCRIPTION (provided by applicant): The overall aim of this STTR proposal is to take an innovative, successful; laboratory based technology and transfer it to the commercial sector. Specifically, we wish to establish the capabilities within the Company to manufacture reliable, robust and inexpensive ultra-micro oxygen sensors suitable for electrochemical applications related to cellular metabolis ...

    STTR Phase I 2003 Department of Health and Human ServicesNational Institutes of Health
  5. Novel pharmacotherapies for treatment of ADHD

    SBC: Biostream Therapeutics, Inc.            Topic: N/A

    DESCRIPTION (provided by applicant): Attention-deficit hyperactivity disorder (ADHD) is a common neuropsychiatric condition characterized by hyperactivity, inattention and impulsivity, typically in school-aged boys. Psychostimulants, including methylphenidate and amphetamines, are commonly used to alleviate symptoms of ADHD. However, these medications are typically associated with undesirable sid ...

    STTR Phase I 2003 Department of Health and Human ServicesNational Institutes of Health
  6. Development of a peptide array synthesis system

    SBC: Boston Array Technologies, Inc.            Topic: N/A

    DESCRIPTION (provided by applicant): The overall goal of phase I and II of this proposal is to develop microarray-based methods for high throughput profiling of proteins. This will be done in two different ways, one based on arrays of 100s of thousands of distinct peptides on 1 cm2 chips that can be used to fingerprint proteins, the other based on thousands or tens of thousands of antibodies again ...

    STTR Phase I 2003 Department of Health and Human ServicesNational Institutes of Health
  7. Sertoli Cell-Treated Umbilical Cord Blood for Stroke

    SBC: SANERON CCEL THERAPEUTICS, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): With the recent observations that stem-like cells outside the central nervous system (CNS) can differentiate into neurons, it is no longer inconceivable to suggest that stem cells derived from human umbilical cord blood (hUCB) could be used for cellular transplant therapy for neurological disorders, such as stroke. However, the greatest confounds of cell trans ...

    STTR Phase I 2003 Department of Health and Human ServicesNational Institutes of Health
  8. SPINAL CORD REPAIR WITH HUMAN UMBILICAL CORD BLOOD CELLS

    SBC: SANERON CCEL THERAPEUTICS, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): With the observations that stem-like cells from outside the central nervous system (CNS) can differentiate into neurons and neural stem cells can differentiate into a variety of blood cells, it is no longer inconceivable to suggest that stem cells present in umbilical cord blood could be used to generate neural cells for transplantation treatment of neurodegen ...

    STTR Phase I 2003 Department of Health and Human ServicesNational Institutes of Health
  9. Method for Discovering Novel Transcriptional Regulators

    SBC: CROSSLINK GENETICS CORPORATION            Topic: N/A

    DESCRIPTION (provided by applicant): Regulation of gene expression by transcription factors is one of the most fundamental biological processes. The pharmaceutical manipulation of this process would open doors toward new approaches to treatment of cancer and other major diseases. We aim to develop a novel, comprehensive technology for manipulation of gene expression based on synthetic analogu ...

    STTR Phase I 2003 Department of Health and Human ServicesNational Institutes of Health
  10. LifeBelt CPR: Combined Thoracic and Sternal Compression

    SBC: Deca-Medics            Topic: N/A

    N/A

    STTR Phase I 2003 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government